Skip to main content
. 2018 Mar 14;11:1756284818759930. doi: 10.1177/1756284818759930

Figure 5.

Figure 5.

C-reactive protein (CRP) concentrations in patients with negative versus positive antidrug antibodies against infliximab in all patients (73 versus 8) (A), in patients with ulcerative colitis (UC) (41 versus 7) (B), and in patients with Crohn’s disease (CD) (32 versus 1) (C). Medians and ranges are shown.